Aptiv reported record fourth-quarter revenue of $5.2 billion, a 3% increase, as the automotive technology leader prepares to spin off its Electrical Distribution Systems business as the independent company Versagen on April 1, 2026.
Despite a sharp sell-off in its shares, HubSpot reports a surge in new contract signings and projects an expanding free cash flow margin, signaling underlying operational strength even as investors remain wary.
Following a price target adjustment by Leerink Partners, Kura Oncology (KURA) is drawing investor focus to its 2026 clinical milestones and commercial strategy for its newly launched AML drug, ziftomenib.
Taiwan Semiconductor Manufacturing Co. (TSMC) has unveiled an aggressive capital expenditure plan for 2026, signaling robust confidence in sustained demand driven by artificial intelligence and high-performance computing, which has spurred a significant rally in its shares and upward revisions from analysts.
A revised analyst price target for Grupo Financiero Banorte (BMV:GFNORTE O) is refocusing investor attention on the Mexican banking giant, highlighting how evolving assessments of risk and growth potential can rapidly reshape a stock's narrative.
A combination of moderating inflation and resilient corporate earnings is setting the stage for sustained stability in stock markets, with the recent rally now encompassing small-caps, value stocks, and multiple sectors.
Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.
Truist Securities raises its price target on Huntington Bancshares (HBAN) following a robust Q4 performance, as the regional bank forecasts record interest income growth and benefits from improving industry tailwinds.
A look back at 2016's recurring bills reveals a stark financial truth: small, consistent savings on expenses like cable, cell plans, or insurance, when invested, could have yielded a significant nest egg by today.
Global insurer Chubb Limited prepares to release its fourth-quarter financial results after Tuesday's market close, with investors weighing solid peer performances against broader sector headwinds.
After a stellar 365% surge in the past three years, XRP faces a challenging horizon. Economic uncertainty, shifting investor sentiment, and the maturation of key growth drivers suggest a potentially turbulent period ahead for the digital asset.
A fresh price target for Euronext Brussels-listed IT services firm Econocom Group has analysts and investors reassessing the company's trajectory. The update reflects evolving views on the company's strategic positioning and market conditions.
As markets look ahead to 2026, a mix of established giants and emerging players in AI and digital advertising present compelling opportunities for investors seeking both growth and value.
Amid broader market uncertainty, companies with high insider ownership and robust earnings forecasts can signal aligned interests and resilience. We examine three such UK-listed firms, from a gold miner to a convenience food giant, where those running the show have significant personal stakes.
Video game giant Take-Two Interactive (TTWO) is scheduled to release its fiscal fourth-quarter earnings after Tuesday's market close. Investors are watching closely for signs of resilience in the gaming sector after recent stock declines and mixed performances from tech peers.
American Financial Group (AFG) is scheduled to release its fourth-quarter earnings after the market closes on Tuesday, with analysts anticipating flat revenue growth. The report comes as the property & casualty insurance sector faces headwinds from policy uncertainty and market volatility.
Prudential Financial (NYSE: PRU) is scheduled to release its fourth-quarter earnings after the market closes on Tuesday, with investors closely watching for signs of resilience in the insurance sector.
As Pfizer prepares to report its fourth-quarter results, investors are weighing the company's strategic pivot beyond its COVID-19 portfolio against a backdrop of expected revenue declines. The report may set the tone for the broader pharmaceutical sector.
As Ingredion prepares to release its fourth-quarter results, investors are weighing whether the company can stabilize after a disappointing prior quarter. The broader staples sector's recent strength offers a cautiously optimistic backdrop.
The research and advisory giant is expected to post modest revenue growth when it reports Tuesday morning, as investors weigh its performance against a mixed backdrop for IT services firms.
